{"id":197050,"date":"2015-03-31T03:51:50","date_gmt":"2015-03-31T07:51:50","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/odds-of-reversing-icu-patients-preferences-to-forgo-life-sustaining-care-vary-penn-study-finds.php"},"modified":"2015-03-31T03:51:50","modified_gmt":"2015-03-31T07:51:50","slug":"odds-of-reversing-icu-patients-preferences-to-forgo-life-sustaining-care-vary-penn-study-finds","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/odds-of-reversing-icu-patients-preferences-to-forgo-life-sustaining-care-vary-penn-study-finds.php","title":{"rendered":"Odds of reversing ICU patients&#39; preferences to forgo life-sustaining care vary, Penn study finds"},"content":{"rendered":"<p><p>    PHILADELPHIA -- Intensive care units across the United States    vary widely in how they manage the care of patients who have    set preexisting limits on life-sustaining therapies, such as    authorizing do-not-resuscitate (DNR) orders and prohibiting    interventions such as feeding tubes or dialysis, according to    new research from the Perelman School of Medicine at the    University of Pennsylvania. Their work is published in the    current issue of JAMA Internal Medicine.  <\/p>\n<p>    \"We've long known that end-of-life and critical care varies    across nations, regions and centers, whether from changes in    local policies, practice culture or resource constraints,\" said    the study's lead author Joanna L. Hart, MD, MSHP, a pulmonary    and critical care physician and post-doctoral research fellow    at Penn. \"But, we hypothesized that by looking at this specific    patient population, we could attribute this variability as an    appropriate response to patient preferences in care, and undue    or unsupported variability. No previous studies we're aware of    have analyzed variations in care for patients who, upon    admission, have similar care requests.\"  <\/p>\n<p>    Hart and colleagues also sought to determine the portion of ICU    patients who are admitted with existing treatment limitations -    which may have been outlined in advance directives or otherwise    ordered by inpatient physician -- and how these patients are    managed in the ICU.  <\/p>\n<p>    The researchers examined a retrospective cohort of patients    from 141 intensive care units in 105 hospitals, for a total of    277,693 patients from April 2001 through December 2008 and    found that 4.8 percent of ICU admissions were patients with    preexisting limits on care. Care limitations for most of these    patients included DNR orders, which included preferences    prohibiting chest compressions, intubation and use of    defibrillation to restart their hearts. Other patients had    documented restrictions on acceptable therapies, ranging from    dialysis to nutritional support such as feeding tubes (21    percent), and four percent expressed a preference for comfort    measures only. Patients admitted with treatment limitations    tended to be older than those without such limits (78 years on    average) and nearly all had preexisting chronic illnesses    conditions, most commonly chronic respiratory disease (14    percent) and chronic kidney disease (13 percent). Most (52    percent) of patients were admitted to the ICU from the    emergency department, and 35 percent died during the hospital    stay studied.  <\/p>\n<p>    But the researchers found that these patients' preferences to    refrain from use of lifesaving measures were often changed    during their stay. Among all patients admitted with treatment    limitations, 23 percent of patients nonetheless received CPR in    the ICU, with great variability among ICUs: with less than five    percent of patients at some ICUs and greater than 90 percent in    other ICUs. Overall, 41 percent of patients who entered with    treatment limitations received one or more forms of life    support, and 18 percent had a reversal of previous treatment    limitations during their ICU stay.  <\/p>\n<p>    The researchers found that when ICU care was managed by a    critical care physician, the odds were greater that the    preexisting limitations on care would change and their care    would be escalated with new forms of life support administered.    Suburban hospitals, when compared to urban settings, were found    to be associated with greater odds that patients surviving an    ICU stay would receive new treatments and have new treatment    limitations established during their stay.  <\/p>\n<p>    \"The variability here is astounding and no matter how hard we    tried, we could not make it go away by accounting for any    differences among the patients admitted to different ICUs,\"    says the study's senior author, Scott Halpern, MD, PhD, MBE,    assistant professor of Medicine, Epidemiology, and Medical    Ethics and Health Policy. \"Surprisingly, for patients who had    already outlined 'I don't want this or that procedure or    treatment at end of life,' escalations of treatment intensity    were nonetheless more common than de-escalations,\" said    Halpern. \"This tendency toward aggressiveness varies widely    depending only on which ICU a patient happens to be admitted    to. There seems to be great potential for better aligning the    outcomes of critical care with the outcomes people desire    through a better understanding of how treatment decisions are    made for patients who can and cannot communicate their    preferences. We suggest that having clear, effective advance    directives along with accompanying conversations with potential    surrogate decision makers (usually family) is the best way to    prevent unwanted care during an ICU stay.\"  <\/p>\n<p>    ###  <\/p>\n<p>    Penn Medicine is one of the world's leading academic medical    centers, dedicated to the related missions of medical    education, biomedical research, and excellence in patient care.    Penn Medicine consists of the Raymond and Ruth Perelman School    of Medicine at the University of Pennsylvania (founded in 1765    as the nation's first medical school) and the University of    Pennsylvania Health System, which together form a $4.9 billion    enterprise.  <\/p>\n<p>    The Perelman School of Medicine has been ranked among the top    five medical schools in the United States for the past 17    years, according to U.S. News & World Report's survey of    research-oriented medical schools. The School is consistently    among the nation's top recipients of funding from the National    Institutes of Health, with $409 million awarded in the 2014    fiscal year.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>See the original post here:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2015-03\/uops-oor033015.php\/RK=0\/RS=ghV11DX3QJ66NtfndmRACmg9gvc-\" title=\"Odds of reversing ICU patients&#39; preferences to forgo life-sustaining care vary, Penn study finds\">Odds of reversing ICU patients&#39; preferences to forgo life-sustaining care vary, Penn study finds<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PHILADELPHIA -- Intensive care units across the United States vary widely in how they manage the care of patients who have set preexisting limits on life-sustaining therapies, such as authorizing do-not-resuscitate (DNR) orders and prohibiting interventions such as feeding tubes or dialysis, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their work is published in the current issue of JAMA Internal Medicine. \"We've long known that end-of-life and critical care varies across nations, regions and centers, whether from changes in local policies, practice culture or resource constraints,\" said the study's lead author Joanna L <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/odds-of-reversing-icu-patients-preferences-to-forgo-life-sustaining-care-vary-penn-study-finds.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-197050","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/197050"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=197050"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/197050\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=197050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=197050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=197050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}